{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:40:12Z","timestamp":1730076012341,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,27]]},"DOI":"10.7759\/cureus.72506","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:24:35Z","timestamp":1730075075000},"source":"Crossref","is-referenced-by-count":0,"title":["Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma Arising in Ulcerative Colitis: An Instructive Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Yuichiro","family":"Hamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironao","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunekazu","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200423","article-title":"EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?","volume":"2013","author":"Allen PB","year":"2013","unstructured":"Allen PB, Laing G, Connolly A, O'Neill C. EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?. BMJ Case Rep. 2013, 2013:bcr2013200423. 10.1136\/bcr-2013-200423","journal-title":"BMJ Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.283","article-title":"Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease","volume":"106","author":"Herrinton LJ","year":"2011","unstructured":"Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2011, 106:2146-53. 10.1038\/ajg.2011.283","journal-title":"Am J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.06.011","article-title":"The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe","volume":"7","author":"Lakatos PL","year":"2013","unstructured":"Lakatos PL, Lovasz BD, David G, et al.. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe. J Crohns Colitis. 2013, 7:385-91. 10.1016\/j.crohns.2012.06.011","journal-title":"J Crohns Colitis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.049460","article-title":"Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine","volume":"54","author":"Kandiel A","year":"2005","unstructured":"Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005, 54:1121-5. 10.1136\/gut.2004.049460","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.181982","article-title":"Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle","volume":"58","author":"Sokol H","year":"2009","unstructured":"Sokol H, Beaugerie L. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle. Gut. 2009, 58:1427-36. 10.1136\/gut.2009.181982","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"7","author":"Beaugerie L","year":"2009","unstructured":"Beaugerie L, Brousse N, Bouvier AM, et al.. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009, 7:1617-25. 10.1016\/S0140-6736(09)61302-7","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.745","article-title":"Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study","volume":"105","author":"Armstrong RG","year":"2010","unstructured":"Armstrong RG, West J, Card TR. Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Am J Gastroenterol. 2010, 105:1604-9. 10.1038\/ajg.2009.745","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21582","article-title":"Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study","volume":"17","author":"Vos AC","year":"2011","unstructured":"Vos AC, Bakkal N, Minnee RC, et al.. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflamm Bowel Dis. 2011, 17:1837-45. 10.1002\/ibd.21582","journal-title":"Inflamm Bowel Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12624","article-title":"Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-\u03b1 therapy in inflammatory bowel disease","volume":"39","author":"Williams CJ","year":"2014","unstructured":"Williams CJ, Peyrin-Biroulet L, Ford AC. Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-\u03b1 therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2014, 39:447-58. 10.1111\/apt.12624","journal-title":"Aliment Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz204","article-title":"Lack of increased risk of lymphoma by thiopurines or biologics in Japanese patients with inflammatory bowel disease: a large-scale administrative database analysis","volume":"14","author":"Kobayashi T","year":"2020","unstructured":"Kobayashi T, Uda A, Udagawa E, Hibi T. Lack of increased risk of lymphoma by thiopurines or biologics in Japanese patients with inflammatory bowel disease: a large-scale administrative database analysis. J Crohns Colitis. 2020, 14:617-23. 10.1093\/ecco-jcc\/jjz204","journal-title":"J Crohns Colitis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.018515","article-title":"Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County","volume":"53","author":"Ljung T","year":"2004","unstructured":"Ljung T, Karl\u00e9n P, Schmidt D, et al.. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut. 2004, 53:849-53. 10.1136\/gut.2003.018515","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans CP","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, et al.. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004, 103:275-82. 10.1182\/blood-2003-05-1545","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-023-01754-5","article-title":"Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapy","volume":"16","author":"Ogiyama H","year":"2023","unstructured":"Ogiyama H, Murayama Y, Tsutsui S, et al.. Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapy. Clin J Gastroenterol. 2023, 16:198-205. 10.1007\/s12328-023-01754-5","journal-title":"Clin J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.05.024","article-title":"Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease","volume":"4","author":"Schwartz LK","year":"2006","unstructured":"Schwartz LK, Kim MK, Coleman M, Lichtiger S, Chadburn A, Scherl E. Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006, 4:1030-4. 10.1016\/j.cgh.2006.05.024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.185","article-title":"Primary rectal diffuse large B-cell lymphoma associated with ulcerative colitis: a case report","volume":"3","author":"Hiyama K","year":"2015","unstructured":"Hiyama K, Terashima H, Nakano Y, Kamiga M, Harada K, Horiguchi H, Mamiya T. Primary rectal diffuse large B-cell lymphoma associated with ulcerative colitis: a case report. Clin Case Rep. 2015, 3:150-5. 10.1002\/ccr3.185","journal-title":"Clin Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.14740\/gr720e","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma involving the colon in a patient with ulcerative pancolitis and polymyositis on long-term methotrexate therapy","volume":"9","author":"Chang MD","year":"2016","unstructured":"Chang MD, Markham MJ, Liu X. Epstein-Barr virus-positive diffuse large B-cell lymphoma involving the colon in a patient with ulcerative pancolitis and polymyositis on long-term methotrexate therapy. Gastroenterol Res. 2016, 9:83-6. 10.14740\/gr720e","journal-title":"Gastroenterol Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-020-00954-8","article-title":"A case of iatrogenic immunodeficiency-associated colonic lymphoma complicating ulcerative colitis","volume":"15","author":"Suzuki K","year":"2020","unstructured":"Suzuki K, Ohe R, Kabasawa T, et al.. A case of iatrogenic immunodeficiency-associated colonic lymphoma complicating ulcerative colitis. Diagn Pathol. 2020, 15:34. 10.1186\/s13000-020-00954-8","journal-title":"Diagn Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-021-01060-2","article-title":"Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report","volume":"21","author":"Suzuki T","year":"2021","unstructured":"Suzuki T, Iwamoto K, Nozaki R, Saiki Y, Tanaka M, Fukunaga M, Yamada K. Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report. BMC Surg. 2021, 21:50. 10.1186\/s12893-021-01060-2","journal-title":"BMC Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-023-01811-z","article-title":"A rare case of Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a patient with ulcerative colitis","volume":"16","author":"Nakada T","year":"2023","unstructured":"Nakada T, Arihiro S, Gunji T, et al.. A rare case of Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a patient with ulcerative colitis. Clin J Gastroenterol. 2023, 16:543-9. 10.1007\/s12328-023-01811-z","journal-title":"Clin J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-021-01832-w","article-title":"Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study)","volume":"56","author":"Miura M","year":"2021","unstructured":"Miura M, Shimizu H, Saito D, et al.. Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study). J Gastroenterol. 2021, 56:1080-91. 10.1007\/s00535-021-01832-w","journal-title":"J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/310382-epstein-barr-virus-positive-diffuse-large-b-cell-lymphoma-arising-in-ulcerative-colitis-an-instructive-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:24:37Z","timestamp":1730075077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/310382-epstein-barr-virus-positive-diffuse-large-b-cell-lymphoma-arising-in-ulcerative-colitis-an-instructive-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.72506","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,27]]}}}